Anti-tumor activity and mechanistic characterization of APE1/Ref-1 inhibitors in bladder cancer

Bladder cancer is the ninth most common cause of cancer-related deaths worldwide. Although cisplatin is used routinely in treating bladder cancer, refractory disease remains lethal for many patients. The recent addition of immunotherapy has improved patient outcomes, however a large cohort of patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer Ther
Main Authors: Fishel, Melissa L., Xia, Hanyu, McGeown, Jack, McIlwain, David W., Elbanna, May, Craft, Ariel A., Kaimakliotis, Hristos Z., Sandusky, George E., Zhang, Chi, Pili, Roberto, Kelley, Mark R., Jerde, Travis J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6844258/
https://ncbi.nlm.nih.gov/pubmed/31413178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-18-1166
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados